Patents by Inventor Gérard Jung

Gérard Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating using hormone-albumin fusion proteins
    Patent number: 7833521
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant of human serum albumin, methods for preparation, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing fusion polypeptides.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: November 16, 2010
    Assignee: Novozymes Biopharma DK A/S
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide
    Publication number: 20090176276
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Application
    Filed: October 29, 2007
    Publication date: July 9, 2009
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gerard Jung, Patrice Yeh
  • Methods of treatment with interferson and albumin fusion protein
    Patent number: 7435410
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Grant
    Filed: June 7, 2005
    Date of Patent: October 14, 2008
    Assignee: Novozymes Biopharma UK Limited
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Patent number: 7410779
    Abstract: The invention includes biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant of human serum albumin, methods for the preparation of such fusion polypeptides, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing such fusion polypeptides.
    Type: Grant
    Filed: January 12, 2006
    Date of Patent: August 12, 2008
    Assignee: Novozymes Biopharma UK Limited
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Insulin and albumin fusion protein
    Patent number: 7094577
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: August 22, 2006
    Assignee: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Interleukin and albumin fusion protein
    Patent number: 7081354
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: July 25, 2006
    Assignee: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Hormone and albumin fusion protein
    Patent number: 7056701
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: June 6, 2006
    Assignee: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Publication number: 20060105429
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Application
    Filed: January 12, 2006
    Publication date: May 18, 2006
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gerard Jung, Patrice Yeh
  • G-CSF and albumin fusion protein
    Patent number: 7041478
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: May 9, 2006
    Assignee: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Methods of treatment with erythropoietin and albumin fusion protein
    Patent number: 6989365
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: January 24, 2006
    Assignee: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Erythropoietin and albumin fusion protein, nucleic acids, and methods thereof
    Patent number: 6987006
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: January 17, 2006
    Assignee: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Interferon and albumin fusion protein
    Patent number: 6972322
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: December 6, 2005
    Assignee: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Publication number: 20050239167
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Application
    Filed: June 7, 2005
    Publication date: October 27, 2005
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gerard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Publication number: 20040086977
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Application
    Filed: November 7, 2003
    Publication date: May 6, 2004
    Applicant: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gerard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Publication number: 20040086976
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Application
    Filed: November 7, 2003
    Publication date: May 6, 2004
    Applicant: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gerard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Patent number: 6686179
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Grant
    Filed: October 29, 2001
    Date of Patent: February 3, 2004
    Assignee: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gérard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Publication number: 20030082747
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Application
    Filed: September 10, 2002
    Publication date: May 1, 2003
    Applicant: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gerard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Publication number: 20030036170
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Application
    Filed: September 10, 2002
    Publication date: February 20, 2003
    Applicant: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominque Guitton, Gerard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Publication number: 20030036172
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Application
    Filed: September 10, 2002
    Publication date: February 20, 2003
    Applicant: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gerard Jung, Patrice Yeh
  • Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
    Publication number: 20030036171
    Abstract: Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
    Type: Application
    Filed: September 10, 2002
    Publication date: February 20, 2003
    Applicant: Aventis Behring L.L.C.
    Inventors: Reinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gerard Jung, Patrice Yeh